BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Katoch S, Sharma V, Patial V. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. World J Gastroenterol 2022; 28(28): 3535-3554 [PMID: 36161051 DOI: 10.3748/wjg.v28.i28.3535]
URL: https://www.wjgnet.com/1948-5182/full/v28/i28/3535.htm
Number Citing Articles
1
Zhenshan Zhang, Leilei Wu, Juan Li, Jiayan Chen, Qi Yu, Hui Yao, Yaping Xu, Liang Liu. Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular CarcinomaJournal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03790-0
2
Han Zhang, Zexuan Zhu, Hui Li, Shan He. Network Biomarker Detection From Gene Co-Expression Network Using Gaussian Mixture Model ClusteringIEEE/ACM Transactions on Computational Biology and Bioinformatics 2023; 20(6): 3523 doi: 10.1109/TCBB.2023.3297388
3
Nicholas Dale D. Talubo, Po-Wei Tsai, Lemmuel L. Tayo. Comprehensive RNA-Seq Gene Co-Expression Analysis Reveals Consistent Molecular Pathways in Hepatocellular Carcinoma across Diverse Risk FactorsBiology 2024; 13(10): 765 doi: 10.3390/biology13100765
4
Ke Zhan, Xin Yang, Shuang Li, Yang Bai. Correlation of endoplasmic reticulum stress patterns with the immune microenvironment in hepatocellular carcinoma: a prognostic signature analysisFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1270774
5
Yi Shang, Takamitsu Morioka, Kazuhiro Daino, Takafumi Nakayama, Mayumi Nishimura, Shizuko Kakinuma. Ionizing radiation promotes, whereas calorie restriction suppresses, NASH and hepatocellular carcinoma in miceInternational Journal of Cancer 2023; 153(8): 1529 doi: 10.1002/ijc.34651
6
A. Khoo, M. Boyer, Z. Jafri, T. Makeham, T. Pham, L. M. Khachigian, P. Floros, E. Dowling, K. Fedder, D. Shonka, J. Garneau, C. H. O’Meara. Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future PerspectivesInternational Journal of Molecular Sciences 2024; 25(5): 2798 doi: 10.3390/ijms25052798
7
Madalina Andreea Robea, Ioana-Miruna Balmus, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Carol Stanciu, Carmen Diana Cimpoesu, Anca Trifan. Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation RelevanceMedicina 2023; 59(9): 1614 doi: 10.3390/medicina59091614
8
Ui-Hyun Park, HyeSook Youn, Eun-Joo Kim, Soo-Jong Um. Shikonin Binds and Represses PPARγ Activity by Releasing Coactivators and Modulating Histone Methylation CodesNutrients 2023; 15(7): 1797 doi: 10.3390/nu15071797
9
Howard D Lee, Li-Yun Yuan. Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?World Journal of Hepatology 2024; 16(5): 684-687 doi: 10.4254/wjh.v16.i5.684
10
Vinesh Sharma, Vikram Patial. Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseasesFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.991059
11
Fereshteh Asgharzadeh, Arghavan Memarzia, Vida Alikhani, Sima Beigoli, Mohammad Hossein Boskabady. Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growthTranslational Oncology 2024; 47: 102039 doi: 10.1016/j.tranon.2024.102039
12
Stephanie Talamantes, Michela Lisjak, Eduardo H. Gilglioni, Camilo J. Llamoza-Torres, Bruno Ramos-Molina, Esteban N. Gurzov. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinomaJHEP Reports 2023; 5(9): 100811 doi: 10.1016/j.jhepr.2023.100811
13
Katarzyna Walczak, Agnieszka Gerkowicz, Dorota Krasowska. PPARs and the Kynurenine Pathway in Melanoma—Potential Biological InteractionsInternational Journal of Molecular Sciences 2023; 24(4): 3114 doi: 10.3390/ijms24043114
14
Lu shan, Yijun Chen, Guo An, Xiaoyu Tao, Chuanqi Qiao, Meilin Chen, Jiaqi Li, Ruichao Lin, Jiarui Wu, Chongjun Zhao. Polyphyllin I exerts anti-hepatocellular carcinoma activity by targeting ZBTB16 to activate the PPARγ/RXRα signaling pathwayChinese Medicine 2024; 19(1) doi: 10.1186/s13020-024-00984-0
15
Xuguang Yang, Bo Deng, Weiwei Zhao, Yangyang Guo, Yaqi Wan, Zhihao Wu, Sheng Su, Jingyan Gu, Xiaoqian Hu, Wenxue Feng, Chencheng Hu, Jia Li, Yanyong Xu, Xiaowu Huang, Yuli Lin. FABP5+ lipid-loaded macrophages process tumor-derived unsaturated fatty acid signal to suppress T-cell antitumor immunityJournal of Hepatology 2024;  doi: 10.1016/j.jhep.2024.09.029
16
Maryam Golmohammadi, Mehraveh Sadeghi Ivraghi, Ekhlas Khammas Hasan, Huldani Huldani, Mohammad Yasin Zamanian, Shiva Rouzbahani, Yasser Fakri Mustafa, Shaker Shanawa Al-Hasnawi, Adeeb Abdulally Abdulhussien Alazbjee, Faranak Khalajimoqim, Fattaneh Khalaj. Protective effects of pioglitazone in renal ischemia–reperfusion injury (RIRI): focus on oxidative stress and inflammationClinical and Experimental Nephrology 2024;  doi: 10.1007/s10157-024-02525-3
17
Ephraim E Parent, Amy M Fowler. Nuclear Receptor Imaging In Vivo—Clinical and Research AdvancesJournal of the Endocrine Society 2023; 7(3) doi: 10.1210/jendso/bvac197